drugset / Trial / NCT01753180

Total Occlusion Study in Coronary Arteries - 5

NCT01753180

Phase 2 Completed 76 enrolled Matrizyme Pharma Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

A prospective, multi-center, double blind, 2 stage, placebo-controlled, phase II study, evaluating acute intra-coronary injected collagenase prior to routine standard-of-care percutaneous revascularization procedures in subjects with chronic total coronary artery occlusions (CTOs).

Timeline

Start
2014-04
Primary completion
2015-12
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagenase Clostridium Histolyticum Protein / enzyme biologic Other

Indications